AptarGroup (NYSE:ATR) Issues Q1 2025 Earnings Guidance

AptarGroup (NYSE:ATR) issued an update on its first quarter 2025 earnings guidance on Thursday morning. The company provided EPS guidance of 1.110-1.190 for the period, compared to the consensus EPS estimate of 1.280. The company issued revenue guidance of -.

AptarGroup Price Performance

Shares of ATR stock traded down $1.88 during trading hours on Thursday, hitting $156.44. 446,562 shares of the company’s stock were exchanged, compared to its average volume of 309,619. The company has a market capitalization of $10.41 billion, a PE ratio of 31.41, a PEG ratio of 2.59 and a beta of 0.59. The company has a current ratio of 1.62, a quick ratio of 1.15 and a debt-to-equity ratio of 0.32. AptarGroup has a 12-month low of $129.37 and a 12-month high of $178.03. The business’s 50 day simple moving average is $160.78 and its 200-day simple moving average is $158.90.

AptarGroup (NYSE:ATR) last posted its quarterly earnings results on Thursday, February 6th. The industrial products company reported $1.52 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.24. AptarGroup had a net margin of 9.40% and a return on equity of 14.92%. On average, equities research analysts anticipate that AptarGroup will post 5.38 earnings per share for the current year.

AptarGroup Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, February 26th. Investors of record on Wednesday, February 5th will be given a dividend of $0.45 per share. The ex-dividend date of this dividend is Wednesday, February 5th. This represents a $1.80 annualized dividend and a yield of 1.15%. AptarGroup’s payout ratio is 36.14%.

AptarGroup announced that its Board of Directors has authorized a stock buyback plan on Thursday, October 10th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the industrial products company to reacquire up to 4.7% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s board believes its stock is undervalued.

Analyst Ratings Changes

Several research analysts recently commented on the stock. Dbs Bank raised shares of AptarGroup from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, October 16th. Raymond James assumed coverage on shares of AptarGroup in a research report on Tuesday, January 7th. They issued an “outperform” rating and a $200.00 price objective on the stock. Robert W. Baird upped their price objective on shares of AptarGroup from $170.00 to $185.00 and gave the company an “outperform” rating in a research note on Monday, October 28th. Bank of America cut AptarGroup from a “buy” rating to a “neutral” rating and set a $173.00 target price on the stock. in a research note on Monday, January 6th. Finally, Jefferies Financial Group upgraded AptarGroup from a “hold” rating to a “buy” rating and boosted their price target for the company from $155.00 to $215.00 in a report on Monday, October 14th. One analyst has rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $190.60.

Insider Activity at AptarGroup

In other news, EVP Kimberly Chainey sold 964 shares of the company’s stock in a transaction dated Friday, November 15th. The shares were sold at an average price of $168.83, for a total value of $162,752.12. Following the sale, the executive vice president now directly owns 7,848 shares of the company’s stock, valued at $1,324,977.84. This represents a 10.94 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 1.00% of the stock is owned by corporate insiders.

AptarGroup Company Profile

AptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments.